Re-irradiation Outcomes in Recurrent Pediatric Ependymoma
Personalized briefing
Discovery of the day · Neurology
Conventionally Fractionated Re-irradiation for Recurrent Ependymoma
Dear Damien Boorman, this is your personalized scientific intelligence briefing — curated for your work in Neurology.
Key finding
Medicine · Neuro-Oncology
Discovery of the day
A long-term study of 150 pediatric patients at St. Jude Children’s Research Hospital demonstrates that a second course of conventionally fractionated radiotherapy can extend survival in recurrent ependymoma, though prognosis remains poor with 10-year progression-free and overall survival rates of 19.5% and 34.3%, respectively. The analysis, spanning from July 1994 to January 2024, found that females had significantly better outcomes, and that craniospinal irradiation did not improve progression-free survival or overall survival for patients with local failure when compared to focal irradiation alone. These findings refine clinical decision-making for a challenging patient population by identifying which patients may benefit from re-irradiation while cautioning that proton therapy was associated with higher rates of necrosis, underscoring the need for careful patient selection and long-term follow-up in this high-risk group.
Novelty
82%
Rigor
94%
Significance
90%
Validity
92%
Clarity
88%
Advertisement
GroupRFQ — join group deals on lab & medical equipment. Pool orders, unlock volume pricing. See open deals →
Your briefing is personalized based on your selected fields, keywords, and research interests.
